Revenue: QQ2 2025 = 1.135 (USD millions), YoY = -41.62%, QoQ = +17.25% (vs QQ2 2024 and QQ1 2025 respectively). Gross Profit: 0.874, Gross Margin = 77.00%, YoY = +109.81%, QoQ = -9.80%. Operating Income: -2.0002, Operating Margin = -176.23%, YoY = +66.24%, QoQ = -15.38%. Net Income: -2.18755, Net Margin = -192.74%, YoY = +54.39%, QoQ = -18.62%. EPS (diluted): -0.0014, YoY = +56.25%, QoQ = -16.67%. EBITDA: -0.099945 (USD millions), EBITDA Margin = -88.06%. Cash Flow: Net cash from operating activities = -0.083878, Free cash flow = -0.083878, Net change in cash = -0.004878, Cash at end of period = 0.049296. Balance Sheet: Total Assets = 0.258423, Total Liabilities = 2.521770, Total Equity = -0.002263347, Cash and equivalents = 0.049296, Short-term debt = 1.425353, Current Liabilities ≈ 2.521770, Current Ratio = 0.0294, Quick Ratio = 0.0294, Cash Ratio = 0.0195, Debt/Asset proxy and other leverage signals indicate solvency risk. Revenue multiple indicators: Price-to-Sales around 1,715x (per data), suggesting a punitive valuation backdrop if earnings trajectory does not improve.Notes: Figures are in USD, reported in thousands or millions per line item; some balance sheet items appear inconsistent with typical reporting scales (e.g., very high liabilities relative to assets, negative equity). The data should be treated with caution and cross-checked against the official 10-Q for QQ2 2025 when available.